Zobrazeno 1 - 10
of 577
pro vyhledávání: '"Gregory R Pond"'
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
In the field of general medicine, class effects, or therapeutic interchangeability, have been declared for several families of drugs including statins, calcium channel blockers and ACE inhibitors. The existence of such class effects enables healthcar
Externí odkaz:
https://doaj.org/article/861132a319e645919ea21c894d139add
Autor:
Bojana Petrovic, Jim A Julian, Clare Liddy, Amir Afkham, Sharon F McGee, Scott C Morgan, Roanne Segal, Jonathan Sussman, Gregory R Pond, Mary Ann O'Brien, Jacqueline L Bender, Eva Grunfeld
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e40725 (2023)
BackgroundCancer poses a significant global health burden. With advances in screening and treatment, there are now a growing number of cancer survivors with complex needs, requiring the involvement of multiple health care providers. Previous studies
Externí odkaz:
https://doaj.org/article/39d4b86390b5408097a3195921f038be
Autor:
Veeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, Brooke Levis, Masoom Haider, Ridhi Agarwal, Mark Emberton, Gregory R Pond, Yemisi Takwoingi, Laurence Klotz, Caroline M Moore, VISION study collaborators
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263345 (2022)
BackgroundTransrectal ultrasound (TRUS) guided biopsy for prostate cancer is prone to random and systemic error and has been shown to have a negative predictive value of 70%. PRECISION and PRECISE are among the first randomised studies to evaluate th
Externí odkaz:
https://doaj.org/article/69cef101b5e942828eb946bdde8574fb
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251886 (2021)
HypothesisThere is limited data on the care and outcomes of individuals with both chronic obstructive pulmonary disease (COPD) and lung cancer, particularly in advanced disease. We hypothesized such patients would receive less cancer treatment and ha
Externí odkaz:
https://doaj.org/article/8bc7c8b810854dcf9c8a2fcc6c268c08
Autor:
Hira S Mian, Gregory R Pond, Tanya M Wildes, Branavan Sivapathasundaram, Jonathan Sussman, Hsien Seow
Publikováno v:
Haematologica, Vol 106, Iss 7 (2020)
Externí odkaz:
https://doaj.org/article/965720541df14d288ea6f6bc0f007a16
Autor:
Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Ronan Flippot, Bradley A McGregor, Lauren C Harshman, Gregory R Pond, Catherine Curran, Kerry L Kilbridge, Xiao X Wei, Toni Choueiri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundImmune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Although the incidence and prevalence of irAEs have been well characterized in the literature, less is known about the cumulative incidence rate
Externí odkaz:
https://doaj.org/article/f9a53e784a40492e874a776edb028735
Autor:
Kay Dias, Anna Dvorkin-Gheva, Robin M Hallett, Ying Wu, John Hassell, Gregory R Pond, Mark Levine, Tim Whelan, Anita L Bane
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0168669 (2017)
Claudin-low breast cancer is a molecular type of breast cancer originally identified by gene expression profiling and reportedly associated with poor survival. Claudin-low tumors have been recognised to preferentially display a triple-negative phenot
Externí odkaz:
https://doaj.org/article/146be580e3a043cd912b1c4b420888d3
Autor:
Ana-Alicia Beltran-Bless, Bader Alshamsan, Mashari Jemaan Alzahrani, John Hilton, Kelly-Anne Baines, Vicky Samuel, Gregory R. Pond, Lisa Vandermeer, Mark Clemons, Gail Larocque
Publikováno v:
The Breast. 69:274-280
Publikováno v:
Journal of Neurosurgery: Pediatrics. 31:275-281
OBJECTIVE Rapid access to neurosurgical decisions and definitive management are vital for the outcome of neurocritical patients. There are unique challenges associated with the provision of services required to maintain critical infrastructure for ru
Autor:
Alisha Sharma, Kathryn Corbett, Maleeha Qazi, Hany Soliman, Arjun Sahgal, Sunit Das, Mary Jane Lim-Fat, Gregory R. Pond, Katarzyna Jerzak
Publikováno v:
Cancer Research. 83:P2-13
Introduction: Leptomeningeal disease (LMD) is a late complication of metastatic cancer that significantly limits patient survival. LMD is most prevalent in patients with melanoma, lung, and breast cancer, with incidence reaching 24.1% among those tre